Study characterizes insulin secretion in response to metabolic stress

April 7, 2016, Journal of Clinical Investigation

The development of type 2 diabetes is linked to persistent inflammation as a consequence of metabolic stress. Prolonged exposure to the proinflammatory molecule IL-1β is associated with reduced insulin secretion by pancreatic β cells, while short-term exposure to IL-1β has been shown to increase insulin levels. Reducing IL-1 signaling in patients with type 2 diabetes has had mixed success in clinical studies, suggesting multiple effects of IL-1β in insulin secretion.

A new study in JCI Insight reveals that IL-1 signaling is an important mediator of islet compensation to metabolic stress. Patrick MacDonald and colleagues at the University of Alberta determined that IL-1β amplifies in healthy human islets. Islets from obese individuals were particularly sensitive to IL-1β stimulation; however, islets from obese subjects with type 2 diabetes were not responsive to IL-1β. In mice, inhibition of IL-1 signaling resulted in symptoms of type 2 diabetes, including glucose intolerance and impaired insulin secretion in response to . Additionally, the authors determined that IL-1β directly promotes insulin secretion by enhancing release of insulin-containing granules.

The results of this study demonstrate that IL-1R signaling is important for glucose homeostasis.

Explore further: Monounsaturated fatty acids may improve adipose dysfunction

More information: Catherine Hajmrle et al. Interleukin-1 signaling contributes to acute islet compensation, JCI Insight (2016). DOI: 10.1172/jci.insight.86055

Related Stories

Monounsaturated fatty acids may improve adipose dysfunction

February 4, 2015
(HealthDay)—Monounsaturated fatty acids (MUFAs) may reduce inflammation and improve insulin sensitivity in adipose tissue, according to research published online Jan. 27 in Diabetes.

Lithium may protect against cartilage decline in osteoarthritis

June 27, 2014
(HealthDay)—Lithium reduces catabolic events in interleukin-1 β (IL-1β)-treated human articular chondrocytes and protects against cartilage degradation in IL-1β-treated mouse knee joints, according to a study published ...

New treatment approach to limit damage after joint bleed

June 12, 2015
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) identified that the cytokine (cell signalling protein) Interleukin-1β (IL-1β) is a crucial factor in the development ...

Type 1 diabetes patients have lower blood levels of four proteins that protect against immune attack

July 29, 2015
Patients with type 1 diabetes have significantly lower blood levels of four proteins that help protect their tissue from attack by their immune system, scientists report.

An antibody that blocks immune signaling offers a promising research tool and potential therapeutic agent

October 22, 2014
Through a combination of natural immune selection and targeted protein engineering, A*STAR researchers have generated an antibody that efficiently blocks a disease-related inflammatory pathway in both human cells and mouse ...

A pharmacological approach to improving pancreatic beta cell growth and function

March 17, 2016
β cells in pancreatic islets are responsible for producing insulin, which is essential to regulate blood glucose homeostasis. In type 1 diabetes, pancreatic β cells are destroyed due to an autoimmune attack, whereas in ...

Recommended for you

Deep brain stimulation found to improve diabetes symptoms

May 24, 2018
A team of researchers from several institutions in the Netherlands and Yale University in the U.S. has found evidence that suggests deep brain stimulation (DBS) can help treat type 2 diabetes. In their paper published in ...

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.